Status: Not yet recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .
This is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type A（Eveotox）in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with upper limb spasticity.
Participants needed: 207
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: JHM BioPharma (Tonghua) Co. , Ltd.Updated: Nov 21, 2025Locations: 2
Eligibility criteria
Participant must be 18 to 80 years of age inclusive, at the time of signing the... [+4]
Previous use of any botulinum toxin within 6 months prior to screening, or plan... [+5]